Teva Pharmaceuticals Cash Flow Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Net Operating Cash Flow | 3,231.0 | 1,813.0 | 2,058.0 |
| Net Investing Cash Flow | (4,137.0) | (1,353.0) | (4,058.0) |
| Net Financing Cash Flow | 1,358.0 | (362.0) | 2,024.0 |
| Net Change in Cash | 366.0 | 156.0 | 56.0 |
| Depreciation & Amortization | 493.0 | 521.0 | 431.0 |
| Capital Expenditures | (681.0) | (542.0) | (390.0) |
| Cash Dividends Paid | (388.0) | (299.0) | (229.0) |
© 2009 Morningstar, Inc. Financial Data provided by
